Skip to main content
FinSpry Logo
FinSpry
KROS logo
KROS
(NASDAQ)
Keros Therapeutics, Inc.
$12.00-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Keros Therapeutics (KROS) Stock Price & Financial Analysis

Keros Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$11.30 - $12.03
52-Week High$22.55
52-Week Low$9.12
Open$11.42
Volume559.05K
Average Volume (3M)559.05K
Market Cap454.31M
Shares Outstanding37.86M
P/E Ratio (TTM)5.09
Price to Sales (P/S)1.81
Price to Book (P/B)1.46
EV/EBITDA2.94
Revenue (TTM)244.06M
Net Income (TTM)87.01M
Free Cash Flow (TTM)105.95M
EPS (TTM)$2.30
Profit Margin35.65%
Operating Margin27.72%
Return on Equity (ROE)28.70%
Debt to Equity0.06
50-Day MA$14.57
200-Day MA$15.79
52-Week Change22.41%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Keros Therapeutics

What is the current stock price for KROS?

As of the latest trading session, KROS stock trades at $12.00. The 52-week range is $9.12–$22.55, with a day range of $11.30–$12.03.

What is the P/E ratio for KROS?

Keros Therapeutics's trailing P/E ratio is 5.1, meaning investors pay $5.1 for every $1 of annual earnings. Keros Therapeutics operates in the Healthcare sector.

Does KROS pay dividends?

Keros Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KROS?

Based on 1 analyst, the consensus for KROS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KROS?

Keros Therapeutics's market capitalization is $454.3M, classifying it as a small-cap company. Keros Therapeutics operates in the Healthcare sector within the Biotechnology industry.